169 related articles for article (PubMed ID: 26229400)
1. Restraint stress induces and exacerbates intestinal inflammation in interleukin-10 deficient mice.
Koh SJ; Kim JW; Kim BG; Lee KL; Kim JS
World J Gastroenterol; 2015 Jul; 21(28):8580-7. PubMed ID: 26229400
[TBL] [Abstract][Full Text] [Related]
2. Aggravation of Established Colitis in Specific Pathogen-free IL-10 Knockout Mice by Restraint Stress Is Not Mediated by Increased Colonic Permeability.
Schultz M; Lai CC; Lindstroem AL; Stein K; Donaldson G; Thompson-Fawcett M; Butt AG
J Crohns Colitis; 2015 Sep; 9(9):754-62. PubMed ID: 26048917
[TBL] [Abstract][Full Text] [Related]
3. Clostridium difficile infection aggravates colitis in interleukin 10-deficient mice.
Kim MN; Koh SJ; Kim JM; Im JP; Jung HC; Kim JS
World J Gastroenterol; 2014 Dec; 20(45):17084-91. PubMed ID: 25493020
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of enterocolitis in the piroxicam-accelerated interleukin-10 knock out mouse--a model mimicking inflammatory bowel disease.
Holgersen K; Kvist PH; Markholst H; Hansen AK; Holm TL
J Crohns Colitis; 2014 Feb; 8(2):147-60. PubMed ID: 23994255
[TBL] [Abstract][Full Text] [Related]
5. Mast cell deficiency exacerbates inflammatory bowel symptoms in interleukin-10-deficient mice.
Zhang H; Xue Y; Wang H; Huang Y; Du M; Yang Q; Zhu MJ
World J Gastroenterol; 2014 Jul; 20(27):9106-15. PubMed ID: 25083083
[TBL] [Abstract][Full Text] [Related]
6. Butein effects in colitis and interleukin-6/signal transducer and activator of transcription 3 expression.
Lee SD; Choe JW; Lee BJ; Kang MH; Joo MK; Kim JH; Yeon JE; Park JJ; Kim JS; Bak YT
World J Gastroenterol; 2015 Jan; 21(2):465-74. PubMed ID: 25593461
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-19 contributes as a protective factor in experimental Th2-mediated colitis.
Fujimoto Y; Azuma YT; Matsuo Y; Kuwamura M; Kuramoto N; Miki M; Azuma N; Teramoto M; Nishiyama K; Izawa T; Nakajima H; Takeuchi T
Naunyn Schmiedebergs Arch Pharmacol; 2017 Mar; 390(3):261-268. PubMed ID: 27942772
[TBL] [Abstract][Full Text] [Related]
8. Irsogladine Maleate Prevents Colitis in Interleukin-10 Gene-Deficient Mice by Reducing Interleukin-12 and -23 Production.
Nakagawa T; Katsuno T; Noguchi Y; Mandai Y; Yoshihama S; Saito K; Maruoka D; Matsumura T; Arai M; Yokosuka O
Biol Pharm Bull; 2015; 38(11):1681-8. PubMed ID: 26521820
[TBL] [Abstract][Full Text] [Related]
9. Early life stress triggers persistent colonic barrier dysfunction and exacerbates colitis in adult IL-10-/- mice.
Lennon EM; Maharshak N; Elloumi H; Borst L; Plevy SE; Moeser AJ
Inflamm Bowel Dis; 2013; 19(4):712-9. PubMed ID: 23446335
[TBL] [Abstract][Full Text] [Related]
10. Physiological stress exacerbates murine colitis by enhancing proinflammatory cytokine expression that is dependent on IL-18.
Matsunaga H; Hokari R; Ueda T; Kurihara C; Hozumi H; Higashiyama M; Okada Y; Watanabe C; Komoto S; Nakamura M; Kawaguchi A; Nagao S; Sekiyama A; Miura S
Am J Physiol Gastrointest Liver Physiol; 2011 Sep; 301(3):G555-64. PubMed ID: 21719737
[TBL] [Abstract][Full Text] [Related]
11. Evidence for oxidative stress in NSAID-induced colitis in IL10-/- mice.
Narushima S; Spitz DR; Oberley LW; Toyokuni S; Miyata T; Gunnett CA; Buettner GR; Zhang J; Ismail H; Lynch RG; Berg DJ
Free Radic Biol Med; 2003 May; 34(9):1153-66. PubMed ID: 12706496
[TBL] [Abstract][Full Text] [Related]
12. Rapid development of colitis in NSAID-treated IL-10-deficient mice.
Berg DJ; Zhang J; Weinstock JV; Ismail HF; Earle KA; Alila H; Pamukcu R; Moore S; Lynch RG
Gastroenterology; 2002 Nov; 123(5):1527-42. PubMed ID: 12404228
[TBL] [Abstract][Full Text] [Related]
13. GPR120, a potential therapeutic target for experimental colitis in IL-10 deficient mice.
Zhao J; Wang H; Shi P; Wang W; Sun Y
Oncotarget; 2017 Jan; 8(5):8397-8405. PubMed ID: 28039475
[TBL] [Abstract][Full Text] [Related]
14. Expression patterns of sirtuin 1-AMPK-autophagy pathway in chronic colitis and inflammation-associated colon neoplasia in IL-10-deficient mice.
Talero E; Alcaide A; Ávila-Román J; García-Mauriño S; Vendramini-Costa D; Motilva V
Int Immunopharmacol; 2016 Jun; 35():248-256. PubMed ID: 27085036
[TBL] [Abstract][Full Text] [Related]
15. Induction of chronic colitis in IL-10 deficient mice requires IL-4.
Specht S; Arriens S; Hoerauf A
Microbes Infect; 2006 Mar; 8(3):694-703. PubMed ID: 16513385
[TBL] [Abstract][Full Text] [Related]
16. Antisense oligonucleotide blockade of tumor necrosis factor-alpha in two murine models of colitis.
Myers KJ; Murthy S; Flanigan A; Witchell DR; Butler M; Murray S; Siwkowski A; Goodfellow D; Madsen K; Baker B
J Pharmacol Exp Ther; 2003 Jan; 304(1):411-24. PubMed ID: 12490618
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of lactococci strains delivering either IL-10 protein or cDNA in a TNBS-induced chronic colitis model.
del Carmen S; Martín Rosique R; Saraiva T; Zurita-Turk M; Miyoshi A; Azevedo V; de Moreno de LeBlanc A; Langella P; Bermúdez-Humarán LG; LeBlanc JG
J Clin Gastroenterol; 2014; 48 Suppl 1():S12-7. PubMed ID: 25291117
[TBL] [Abstract][Full Text] [Related]
18. NHE3 modulates the severity of colitis in IL-10-deficient mice.
Larmonier CB; Laubitz D; Thurston RD; Bucknam AL; Hill FM; Midura-Kiela M; Ramalingam R; Kiela PR; Ghishan FK
Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G998-G1009. PubMed ID: 21415416
[TBL] [Abstract][Full Text] [Related]
19. VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.
Yadav M; Huang MC; Goetzl EJ
Cell Immunol; 2011; 267(2):124-32. PubMed ID: 21295288
[TBL] [Abstract][Full Text] [Related]
20. Substance P regulates Th1-type colitis in IL-10 knockout mice.
Weinstock JV; Blum A; Metwali A; Elliott D; Bunnett N; Arsenescu R
J Immunol; 2003 Oct; 171(7):3762-7. PubMed ID: 14500676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
